Frontiers Retracts Corrigendum on ABTL0812 in Glioblastoma Over Image Concerns
Frontiers in Oncology has retracted a 2025 corrigendum on the anticancer effects of ABTL0812 in glioblastoma models after the authors ...
Frontiers in Oncology has retracted a 2025 corrigendum on the anticancer effects of ABTL0812 in glioblastoma models after the authors ...
PLOS ONE has retracted a mouse study on pyrroloquinoline quinone after duplicated and overlapping image panels were found across multiple ...
PLOS One has retracted a 2018 study on metformin's effects on Betta splendens aggression after the institution confirmed no valid ...
PLOS ONE has retracted a study claiming resveratrol kills osteosarcoma cancer stem cells via STAT3 inhibition after overlapping images, flawed ...
A PNAS audit of 500,000 science, engineering, and computing papers finds fabricated references in every field examined, with the affected ...
PLOS One editors have issued an Expression of Concern for a 2023 study on decoupling agricultural pollution and carbon reduction ...
PLOS One issued an Expression of Concern for a 2023 coal-mine dust-control modeling paper because of concerns about the integrity ...
Frontiers in Cellular Neuroscience has retracted a 2020 rat study claiming the grape pomace extract Taurisolo protects the brain from ...
PLOS One editors have issued an Expression of Concern for a 2024 study on China's sports lottery development path to ...
A new PLOS Computational Biology perspective sets out ten practical rules defining where AI assistance in computational biology is legitimate ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine